Chemical manufacturer Evonik has acquired a share into Friedrich Schiller University burn healing spinout JeNaCell.
The share was acquired as part of a series A round, the size of which was unannounced, which was also supported by state-backed investors Bmt Beteiligungsmanagement Thüringen and High-Tech-Gründerfonds, Thuringia Foundation for Technology, Innovation and Research and the Sparkasse Jena bank.
JeNaCell is developing a treatment for burn and chronic wounds which utilises nanocellulose. The material uses plant-based cellulose and nanostructured materials to produce an absorbent, tear-resistant, and moisture regulating wound dressing which is less painful than traditional dressings.
Bernhard Mohr, head of venture capital at Evonik, said: “JeNaCell is an outstanding strategic fit for Evonik. The company’s technology supplements our competencies in biotechnology and in the area of delivery systems for active medical ingredients.”
- News & Analysis
- Home
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Publications
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- Video
- Subscribe
- Newsletters
- Events
Evonik shares in JeNaCell’s healing
Jul 9, 2015 •
LEADERSHIP SOCIETY
Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.More featured content
Can University of Kentucky researchers bring new flavours to whisky? The University of Kentucky has formed an industry-university partnership to advance aspects such as sustainable agriculture in the whiskey distilling industry.Can University of Kentucky researchers bring new flavours to whisky?
The University of Kentucky has formed an industry-university partnership to advance aspects such as sustainable agriculture in the whiskey distilling industry.
UK universities ready to pick up the pace of commercialisation in 2025 The UK stands to benefit from the work of the past 12 months to push more university research-led innovation into the marketplace.UK universities ready to pick up the pace of commercialisation in 2025
The UK stands to benefit from the work of the past 12 months to push more university research-led innovation into the marketplace.
About us
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
Navigation
test regLogin
Not yet subscribed?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.